KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $45,354,000 | +6.8% | 252,234 | -38.4% | 0.05% | +4.5% |
| Q2 2017 | $42,474,000 | +11.8% | 409,707 | -15.4% | 0.04% | +12.8% |
| Q1 2017 | $37,998,000 | +43.5% | 484,109 | -18.0% | 0.04% | +34.5% |
| Q4 2016 | $26,471,000 | +36.9% | 590,343 | +70.5% | 0.03% | +38.1% |
| Q3 2016 | $19,337,000 | +28.8% | 346,171 | +15.3% | 0.02% | +23.5% |
| Q2 2016 | $15,008,000 | +15.3% | 300,160 | +5.8% | 0.02% | +13.3% |
| Q1 2016 | $13,020,000 | -26.0% | 283,601 | -0.7% | 0.02% | -28.6% |
| Q4 2015 | $17,595,000 | +16.5% | 285,536 | +5.3% | 0.02% | +16.7% |
| Q3 2015 | $15,104,000 | -6.0% | 271,266 | +3.0% | 0.02% | 0.0% |
| Q2 2015 | $16,060,000 | – | 263,415 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
| RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
| DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
| Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
| Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
| EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
| Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
| BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |